Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking (NCT02224391) | Clinical Trial Compass
CompletedNot Applicable
Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking
United States311 participantsStarted 2016-01-20
Plain-language summary
This randomized clinical trial studies how well a smartphone-delivered attentional bias modification training works in helping patients quit smoking. Smartphone-delivered attentional bias modification training may help patients quit smoking by reducing the attentional bias (the tendency of one's perception to be affected by their recurring thoughts) towards smoking cues that developed over time as a result of conditioning processes through which smoking cues become important.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Smoke an average of 5 or more cigarettes or little cigars per day (CPD) prior to telephone screen
* Produce an expired carbon monoxide (CO) level greater than or equal to 6 parts per million (ppm) or a NicAlert reading of \> 2
* Have a working telephone
* Interested in quitting smoking in the next 30 days
* Fluency in spoken and written English
* Must sign the picture consent form
Exclusion Criteria:
* Taking psychotropic, anticonvulsive, or narcotic medication
* Meet criteria for a current major depressive episode or suicidality
* Have a history of neurological illness or closed head injury
* Report uncorrected vision problems
* Involved in current smoking cessation activity
* Testing positive on a urine drug screen for drugs of abuse/potential abuse
* Women who are pregnant or breastfeeding
* Considered by the investigator to be an unsuitable or unstable candidate (e.g., due to cognitive impairment)
* Shares the same address as a currently enrolled participant
* Unwilling to alter or remove hairstyle, hair extensions, or wig during the clinic visits to allow for correct electroencephalography (EEG) sensor placement
* Reports diagnosis of seizure disorder
* Unwilling to use nicotine replacement therapy (NRT) patches
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.